Apimeds Pharmaceuticals US, Inc. Leases Disclosure
Note 11 LEASES
Operating Lease
On December 12, 2025, the Company entered into an operating lease for office space located in San Diego California, United States. The lease has a term of 3 years, commencing on January 1, 2026, and expiring on December 31, 2028. The lease provides for monthly base rent of $5,940.90, subject to annual escalation of 3%. The Company’s incremental borrowing rate used to discount the lease liability was 5%.
As of December 31, 2025, the Company had made only the initial signing payment of $18,362. Remaining future lease payments had not yet commenced.
Balance Sheet Classification
Operating Lease
| December 31, 2025 | ||||
| Right-of-use asset, net | $ | 187,395 | ||
| Lease liability — current | $ | 39,578 | ||
| Lease liability — non-current | 129,454 | |||
| Total lease liability | $ | 169,032 | ||
Lease Cost
| Year Ended 12/31/2025 | ||||
| Operating lease cost | $ | |||
| Short-term lease cost | ||||
| Total lease cost | $ | |||
Future Minimum Lease Payments
| Year Ending December 31, 2025 | Amount | |||
| 2026 | $ | 47,527 | ||
| 2027 | 67,310 | |||
| 2028 | 69,330 | |||
| Thereafter | ||||
| Total undiscounted lease payments | 184,167 | |||
| Less: imputed interest | (15,135 | ) | ||
| Present value of lease liabilities | $ | 169,032 | ||
Supplemental Information
| Year Ended 12/31/2025 | ||||
| Cash paid for amounts included in lease liabilities | $ | |||
| Weighted-average remaining lease term (years) | 2.9 | |||
| Weighted-average discount rate | 5.0 | % | ||
About Leases Disclosures
Lease disclosures under ASC 842 provide a comprehensive view of a company's leased asset portfolio, including the split between operating and finance leases, discount rates used to present-value future payments, and the maturity schedule of lease obligations. This section reveals a significant source of off-balance-sheet commitments that were largely hidden before the current standard.
Key signals: the weighted-average discount rate affects the size of recorded lease liabilities — a higher rate reduces the reported obligation, so compare the chosen rate against the company's incremental borrowing rate. The operating versus finance lease mix affects both EBITDA and operating income presentation. Watch the maturity table for concentration risk: large payment cliffs in specific years may create cash flow pressure. Variable lease payments excluded from the liability measurement represent real obligations that do not appear on the balance sheet. Compare total lease costs against prior-year operating lease expense to assess the true economic burden.